Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 691
interventional 513
Observational 158
Registry 20

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 159
Drug|placebo 149
Other 47
Biological 30
Device 21
Behavioral 20
Biological|placebo 16
Procedure 14
Dietary Supplement 10
Dietary Supplement|placebo 9
Other|placebo 5
Biological|Procedure 3
Dietary Supplement|Drug 3
Drug|Other 3
Drug|Procedure 3
Biological|Other 2
Device|Procedure 2
Diagnostic Test 2
Drug|placebo|Procedure 2
Behavioral|Other 1
Biological|Diagnostic Test|Drug 1
Biological|Drug 1
Biological|Drug|placebo 1
Device|Drug 1
Device|Other 1
Device|placebo 1
Diagnostic Test|Drug 1
Diagnostic Test|Drug|Other 1
Dietary Supplement|Other 1
Drug|Genetic 1
Drug|Other|placebo 1
Drug|Other|Procedure 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 118
NA 30
United Kingdom 20
France 19
Denmark 18
China 17
Germany 17
Canada 16
Japan 13
Israel 11
Italy 9
Netherlands 8
Belgium 6
United States|Canada 6
Korea, Republic of 5
Spain 5
Australia 4
Norway 4
Sweden 4
United States|Canada|Puerto Rico 4
Hong Kong 3
India 3
Switzerland 3
Austria|Belarus|Belgium|Canada|Czechia|France|Germany|Hungary|Italy|Poland|Serbia|Slovakia|Slovenia|Spain|Ukraine|United Kingdom 2
Czechia 2
Finland 2
United States|Argentina|Australia|Austria|Belarus|Belgium|Bosnia and Herzegovina|Brazil|Canada|Chile|China|Colombia|Croatia|Czechia|Egypt|Estonia|Finland|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Norway|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 2
United States|Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Colombia|Croatia|Czechia|Estonia|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Lebanon|Lithuania|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Switzerland|Turkey|Ukraine|United Kingdom 2
United States|Argentina|Australia|Austria|Belgium|Canada|China|Croatia|Czechia|Denmark|France|Germany|Hungary|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Poland|Romania|Russian Federation|Saudi Arabia|Serbia|Slovakia|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 2
United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Serbia|Slovakia|South Africa|Spain 2
United States|Bulgaria|Canada|Hungary|Latvia|Mexico|Poland|Russian Federation|Serbia|Switzerland|Ukraine 2
United States|Bulgaria|Georgia|Germany|Greece|Hungary|Ireland|Israel|Italy|Moldova, Republic of|Netherlands|Poland|Russian Federation|Serbia|Spain|Ukraine|United Kingdom 2
Argentina|Belgium|Brazil|Canada|Chile|Czech Republic|Estonia|Hungary|Italy|Russian Federation|Singapore|South Africa|Spain|Sweden 1
Australia|Belgium|Czech Republic|Denmark|France|Germany|Hungary|Israel|Italy|Poland|Russian Federation|South Africa|Spain|Sweden|United Kingdom 1
Australia|Belgium|Estonia|France|Israel|Italy|Latvia|Lithuania|Poland|Romania|Russian Federation|Slovakia|Sweden|Ukraine|United Kingdom 1
Australia|Bulgaria|Czechia|Estonia|Hungary|India|Italy|Korea, Republic of|Latvia|Malaysia|New Zealand|Poland|Romania|Russian Federation|Serbia|South Africa|Turkey|Ukraine 1
Australia|China|Korea, Republic of|Taiwan 1
Austria 1
Austria|Belgium|Canada|Czechia|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Netherlands|Norway|Portugal|Romania|Singapore|South Africa|Spain|Sweden|Switzerland|United Kingdom 1
Austria|Belgium|France|Germany|Netherlands 1
Austria|Belgium|France|Israel|Italy|Netherlands 1
Belarus|India|Turkey|Ukraine 1
Belgium|Brazil|Chile|Czech Republic|Denmark|France|Hungary|Israel|Italy|Mexico|Netherlands|Poland|Slovakia|South Africa|Spain|Sweden|United Kingdom 1
Belgium|Canada|Germany|Norway|Sweden 1
Belgium|Czech Republic|Denmark|Finland|Germany|Netherlands|Norway|Sweden 1
Belgium|Czech Republic|Denmark|Germany|Norway|Slovakia|Spain 1
Belgium|Czech Republic|Germany|Hungary|Poland|Russian Federation 1
Belgium|Czech Republic|Latvia|Slovakia 1
Belgium|Finland|France|Italy|Spain 1
Belgium|France 1
Belgium|France|Netherlands|United Kingdom 1
Belgium|Germany|United Kingdom 1
Belgium|Hungary|Netherlands 1
Belgium|Hungary|Slovakia|Spain 1
Belgium|Poland|Spain|United Kingdom 1
Belgium|United States|Argentina|Austria|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Denmark|Egypt|France|Germany|Greece|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|Slovenia|South Africa|Spain|Sweden|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
Bulgaria|Czechia|Hungary|Latvia|Lithuania|Poland|Ukraine|United Kingdom 1
Bulgaria|Hungary|Poland 1
Bulgaria|United States|Argentina|Australia|Brazil|Colombia|Croatia|Czechia|Greece|Hungary|Latvia|Lithuania|Malaysia|New Zealand|Poland|Russian Federation|Turkey|Ukraine 1
Canada|Belgium|Netherlands|Sweden 1
Canada|Finland|Israel|Italy|Poland|Spain 1
Canada|Sweden|Ukraine|United States|Australia|Austria|Belgium|Bulgaria|Czech Republic|Denmark|France|Germany|Hungary|India|Israel|Japan|Lithuania|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa 1
Canada|United States|Australia|Belgium|Brazil|Czech Republic|France|Germany|India|Ireland|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Puerto Rico|South Africa|Switzerland|United Kingdom 1
Czech Republic|France|Germany|Italy|Poland|United Kingdom 1
Czech Republic|Italy 1
Czechia|France|Germany|Hungary|Italy|Poland|United Kingdom 1
Czechia|Netherlands|Poland 1
Denmark|Germany|Netherlands|Norway|Spain|United Kingdom 1
Denmark|Korea, Republic of|United States|Australia|Austria|Belgium|Brazil|Canada|Colombia|Croatia|Czechia|Estonia|France|Germany|Hungary|Israel|Italy|Japan|Latvia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Ukraine|United Kingdom 1
France|Greece|Israel|Italy|Korea, Republic of|Serbia 1
France|Israel|Italy 1
France|United States|Belgium|Canada|Colombia|Czechia|Germany|Hungary|India|Ireland|Poland|Romania|South Africa|Spain|United Kingdom 1
Georgia|Germany|Moldova, Republic of|Ukraine 1
Georgia|Moldova, Republic of|Ukraine 1
Germany|Israel|Netherlands|Singapore|Sweden|Switzerland|United Kingdom 1
Germany|United Kingdom 1
Hungary 1
India|United States|Australia|Austria|Belgium|Bulgaria|Canada|Czech Republic|Denmark|France|Germany|Hungary|Israel|Japan|Latvia|Lithuania|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Sweden|Ukraine 1
Ireland|United Kingdom 1
Israel|Netherlands|Denmark|France|Germany|United States|Austria|Belgium|Canada|Poland 1
Israel|Slovakia|United States|Argentina|Australia|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Croatia|Czechia|Denmark|Estonia|Germany|Hungary|Italy|Japan|Korea, Republic of|Lithuania|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Spain|Sweden|Turkey|Ukraine|United Kingdom 1
Israel|Spain 1
Israel|United States|Argentina|Australia|Belgium|Bosnia and Herzegovina|Brazil|Bulgaria|Canada|Croatia|Czechia|Denmark|Estonia|Germany|Hungary|Italy|Japan|Korea, Republic of|Lithuania|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
Italy|Lithuania|Poland|Russian Federation 1
Japan|United States|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|Croatia|Czechia|France|Georgia|Germany|Greece|Hong Kong|Hungary|India|Ireland|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Netherlands|New Zealand|Norway|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Ukraine|United Kingdom 1
Japan|United States|Argentina|Australia|Austria|Belgium|Bulgaria|Canada|Croatia|Czechia|France|Georgia|Germany|Greece|Hong Kong|Hungary|India|Ireland|Israel|Italy|Korea, Republic of|Malaysia|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Ukraine|United Kingdom 1
Jordan 1
Lebanon 1
Mexico 1
Netherlands|United Kingdom 1
New Zealand 1
Poland|United States|Argentina|Australia|Austria|Belgium|Canada|Czech Republic|Denmark|France|Germany|Hungary|Israel|New Zealand|Norway|Portugal|Spain|Switzerland 1
Portugal 1
Russian Federation 1
Ukraine|Czechia|France|Germany|Hungary|Poland|Russian Federation|Serbia|Spain|Sweden 1
Ukraine|United States|Australia|Belgium|Bulgaria|Canada|France|Germany|Hungary|Israel|Netherlands|Poland|Romania|Russian Federation 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Bulgaria|Canada|Croatia|Czechia|Georgia|Germany|Greece|Hungary|Israel|Italy|Korea, Republic of|Latvia|Moldova, Republic of|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belarus|Belgium|Bulgaria|Canada|Croatia|Czechia|Georgia|Germany|Greece|Hungary|Israel|Italy|Korea, Republic of|Latvia|Moldova, Republic of|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Bosnia and Herzegovina|Brazil|Canada|Chile|China|Colombia|Croatia|Czechia|Egypt|Estonia|Finland|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|Norway|Poland|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Colombia|Croatia|Czechia|Denmark|Estonia|France|Germany|India|Greece|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Norway|Philippines|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Turkey|Ukraine|United Kingdom|Vietnam 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Czechia|Denmark|France|Germany|Greece|Hungary|United Kingdom|Israel|Italy|Korea, Republic of|Lithuania|Mexico|Netherlands|Poland|Romania|Spain|Switzerland 1
United States|Argentina|Australia|Austria|Belgium|Canada|Croatia|Czechia|Denmark|France|Georgia|Germany|Hungary|India|Ireland|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Moldova, Republic of|Netherlands|Poland|Romania|Russian Federation|Saudi Arabia|Serbia|Slovakia|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Colombia|Croatia|Czechia|Denmark|Estonia|France|Germany|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|Netherlands|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|Spain|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|China|Czechia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Netherlands|Poland|Portugal|Romania|Russian Federation|Spain|Sweden|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|Czech Republic|Denmark|France|Germany|Hungary|India|Korea, Republic of|Mexico|Netherlands|New Zealand|Peru|Poland|Portugal|Romania|Russian Federation|Singapore|South Africa|Spain|Sweden|Taiwan|United Kingdom 1
United States|Argentina|Australia|Brazil|Bulgaria|Estonia|France|Hong Kong|Mexico|Poland|Russian Federation|Serbia|Slovakia|Ukraine 1
United States|Argentina|Australia|Brazil|Germany|Mexico|Poland|Russian Federation|Ukraine 1
United States|Argentina|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|China|Colombia|Croatia|Denmark|Egypt|France|Germany|Greece|Israel|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Malaysia|Mexico|Netherlands|New Zealand|Poland|Sweden|Portugal|Puerto Rico|Romania|Russian Federation|Serbia|Singapore|Slovakia|Slovenia|South Africa|Spain|Switzerland|Taiwan|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Belgium|Bosnia and Herzegovina|Bulgaria|Canada|Colombia|Estonia|Greece|Hungary|Ireland|Japan|Korea, Republic of|Lebanon|Mexico|New Zealand|Portugal|Slovakia|Spain|Switzerland|Turkey|Ukraine 1
United States|Australia 1
United States|Australia|Austria|Belgium|Brazil|Canada|Colombia|Croatia|Czech Republic|Denmark|Estonia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Latvia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|Colombia|Croatia|Czech Republic|Denmark|Estonia|France|Germany|Hungary|Israel|Korea, Republic of|Latvia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|France|Germany|Hungary|Italy|Mexico|Netherlands|Poland|South Africa 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|Denmark|France|Germany|Hungary|Israel|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|France|Germany|Hungary|Israel|Korea, Republic of|Latvia|Lithuania|New Zealand|Poland|Romania|Russian Federation|Spain|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|Czechia|France|Germany|Hungary|Israel|Latvia|Lithuania|New Zealand|Poland|Romania|Spain|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Colombia|Croatia|Czech Republic|Denmark|Estonia|France|Germany|Hungary|Israel|Italy|Japan|Latvia|Netherlands|New Zealand|Poland|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|Denmark|Estonia|France|Germany|Greece|Hungary|Italy|Latvia|Netherlands|Norway|Poland|Russian Federation|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|Hungary|Israel|Japan|New Zealand|Poland|Slovakia|Spain|United Kingdom 1
United States|Australia|Austria|Brazil|Croatia|Czechia|Germany|Israel|Italy|Japan|Lithuania|Netherlands|Poland|Romania|Russian Federation|Serbia|South Africa|United Kingdom 1
United States|Australia|Belarus|Belgium|Bulgaria|Canada|Chile|Croatia|Czechia|Denmark|Estonia|France|Georgia|Germany|Hungary|India|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Moldova, Republic of|Netherlands|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Australia|Belarus|Belgium|Bulgaria|Canada|Chile|Croatia|Czechia|Estonia|Georgia|Hungary|India|Italy|Korea, Republic of|Latvia|Moldova, Republic of|Poland|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine 1
United States|Australia|Belgium|Bulgaria|Canada|Greece|Hungary|Israel|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Slovakia|Ukraine 1
United States|Australia|Belgium|Canada|Czech Republic|Germany|Hungary|Israel|New Zealand|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|Denmark|France|Georgia|Hungary|Japan|Lithuania|Moldova, Republic of|Netherlands|Poland|Romania|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Poland|Russian Federation|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|Germany|Hungary|Israel|Korea, Republic of|Malaysia 1
United States|Australia|Belgium|Canada|Czechia|Germany|Hungary|Israel|New Zealand|Spain|United Kingdom 1
United States|Australia|Belgium|Germany|Israel|Italy|Korea, Republic of|Saudi Arabia|Serbia|Spain|Turkey 1
United States|Australia|Bulgaria|Canada|Czechia|France|Germany|Hungary|Italy|Netherlands|New Zealand|Poland|Russian Federation|Ukraine 1
United States|Australia|Bulgaria|Canada|France|Georgia|Germany|Greece|Hungary|Israel|Japan|Korea, Republic of|Poland|Portugal|Serbia|Slovakia|South Africa|Spain|Taiwan|Ukraine 1
United States|Australia|Bulgaria|Hungary|Italy|Japan|Poland|Russian Federation|Slovakia|Spain|Thailand|Turkey 1
United States|Australia|Poland|Slovakia|United Kingdom 1
United States|Austria|Belgium|Canada|Czech Republic|Germany|Hungary|Italy|Netherlands|Poland|Puerto Rico|Slovakia|Sweden 1
United States|Austria|Belgium|Canada|Czechia|Denmark|France|Germany|Hungary|Israel|Italy|Japan|Netherlands|Poland|Romania|Slovakia|Spain|Switzerland|Ukraine|United Kingdom 1
United States|Austria|Belgium|Canada|Germany|Greece|Italy|Japan|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|United Kingdom 1
United States|Austria|Belgium|Canada|Germany|Italy|Japan|Korea, Republic of|Poland|Russian Federation|Spain|United Kingdom 1
United States|Austria|Bulgaria|Canada|Czechia|Denmark|Georgia|Germany|Hungary|Israel|Italy|Korea, Republic of|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Turkey|Ukraine 1
United States|Austria|Bulgaria|Canada|France|Germany|Hungary|Netherlands|Poland|Romania|Spain 1
United States|Belarus|Bosnia and Herzegovina|Bulgaria|Croatia|Czechia|Netherlands|North Macedonia|Poland|Portugal|Romania|Russian Federation|Serbia|Spain|Ukraine|United Kingdom 1
United States|Belarus|Bosnia and Herzegovina|Croatia|Georgia|Hungary|Moldova, Republic of|Poland|Russian Federation|Serbia|Ukraine 1
United States|Belarus|Bulgaria|Canada|France|Germany|Hungary|Ireland|Israel|Italy|Poland|Romania|Russian Federation|Serbia|Spain|Ukraine|United Kingdom 1
United States|Belarus|Canada|Croatia|Czech Republic|Estonia|Hungary|Latvia|Lithuania|Poland|Puerto Rico|Romania|Russian Federation|Serbia|Ukraine 1
United States|Belgium|Brazil|France|Israel|Italy|Korea, Republic of|Netherlands|Poland|Spain|Taiwan 1
United States|Belgium|Bulgaria|Canada|Czech Republic|France|Germany|Hungary|Netherlands|Poland|Russian Federation|Ukraine 1
United States|Belgium|Canada 1
United States|Belgium|Canada|Czechia|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Serbia|Slovakia|South Africa|Spain|Ukraine|United Kingdom 1
United States|Belgium|Canada|Denmark|Netherlands 1
United States|Belgium|Canada|France|Germany|Hungary|Israel|Netherlands|Poland|Ukraine|United Kingdom 1
United States|Belgium|Canada|France|Germany|Italy|Netherlands|Spain|United Kingdom 1
United States|Belgium|Canada|France|Hungary|Israel|Netherlands|Poland|Ukraine|United Kingdom 1
United States|Belgium|Canada|Germany|Hungary|Italy|Slovakia|Sweden 1
United States|Belgium|Canada|Germany|Netherlands|United Kingdom 1
United States|Belgium|Canada|Hungary 1
United States|Belgium|Canada|Hungary|Moldova, Republic of|Netherlands|Romania 1
United States|Belgium|Czech Republic|India|Poland|Russian Federation|Slovakia|Ukraine|United Kingdom 1
United States|Belgium|Italy|Korea, Republic of|Netherlands|Poland 1
United States|Brazil|Canada|Czechia|Denmark|Germany|Hungary|India|Israel|Italy|Mexico|Poland|Slovakia|South Africa|Ukraine 1
United States|Bulgaria|Canada|Czechia|Estonia|France|India|Korea, Republic of|Netherlands|Poland|Russian Federation|Serbia|Slovakia|South Africa|Ukraine|United Kingdom 1
United States|Bulgaria|Canada|Czechia|Estonia|Hungary|Latvia|Lithuania|Poland|Russian Federation|Ukraine 1
United States|Bulgaria|Canada|Hungary|Poland|Slovakia 1
United States|Canada|Croatia|Poland|Romania 1
United States|Canada|Czech Republic|Hungary|Latvia|Romania|Russian Federation|Ukraine 1
United States|Canada|Czech Republic|Hungary|Poland|Russian Federation|Slovakia 1
United States|Canada|Czechia|Hungary|Netherlands|Poland|Serbia 1
United States|Canada|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|Spain|United Kingdom 1
United States|Canada|Hungary|Israel|Poland|Slovakia|United Kingdom 1
United States|Canada|India|Mexico 1
United States|Canada|Israel 1
United States|Canada|Israel|Japan|Korea, Republic of 1
United States|China 1
United States|China|Poland|Puerto Rico|Ukraine 1
United States|Czechia|Hungary 1
United States|Czechia|Hungary|Poland|Romania|Russian Federation|Serbia 1
United States|Denmark|Finland|Ireland|Israel|Slovenia|United Kingdom 1
United States|Denmark|Germany|Poland 1
United States|Georgia|Hungary|Moldova, Republic of|Ukraine 1
United States|Georgia|Moldova, Republic of 1
United States|Germany 1
United States|Germany|Netherlands|Poland|Russian Federation|Sweden|United Kingdom 1
United States|Germany|New Zealand 1
United States|Japan|Poland|Slovakia|Spain|United Kingdom 1
United States|Lithuania|Poland|Slovakia 1
United States|Puerto Rico 1

Sites per Study

Site_count Study_Count
1 244
2 23
3 15
4 7
5 8
6 4
7 8
8 6
9 3
10 1
11 4
12 5
13 3
14 2
15 3
16 5
17 1
18 3
19 5
20 4
21 1
22 4
23 4
24 2
25 2
26 2
27 2
28 4
29 1
30 3
31 2
33 5
34 3
35 1
36 2
37 2
38 1
39 1
40 1
41 2
42 1
43 1
44 1
45 3
47 1
50 1
51 1
52 2
55 1
57 1
58 2
59 2
60 2
61 1
62 2
64 3
65 1
66 2
68 1
69 1
71 2
72 2
75 1
76 1
77 1
78 1
80 1
82 1
86 1
88 3
89 1
90 1
92 1
93 1
94 1
95 1
96 1
97 1
99 2
102 1
104 1
105 5
108 2
111 1
114 1
115 1
117 1
119 1
120 1
123 1
125 1
126 1
134 1
135 1
136 1
142 1
144 1
150 1
166 1
173 2
174 1
178 1
182 1
190 1
195 1
207 1
208 1
210 1
245 2
253 1
262 1
275 1
298 1
305 1
307 1
309 1
323 1
330 1
343 1
372 2
378 1
382 1
409 1
433 1
435 1
463 1
516 1
524 1
586 1
590 1
855 1

Phase

Phase Study_Count
N/A 127
Phase 2 123
Phase 3 120
Phase 1 63
Phase 4 46
Phase 1/Phase 2 17
Phase 2/Phase 3 13
Early Phase 1 4

Number of Arms

Number_of_Arms Count_of_Studies
1 98
2 241
3 67
4 26
5 19
6 8
7 1
8 3
10 4
12 1
14 1
16 1
NA 43

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 12 2.00 3.00000 3.00000 1.000 15.0000 13.0000 1.0000
1st Qu. 12 30.25 19.00000 20.00000 45.000 40.0000 155.0000 32.0000
Median 16 72.00 32.00000 39.00000 100.000 120.0000 359.0000 116.5000
Mean 26 793779.66 43.25397 65.52941 120.157 367.3077 482.3866 163.2174
3rd Qu. 30 143.00 53.50000 60.00000 180.000 720.0000 670.0000 200.0000
Max. 60 99999999.00 213.00000 300.00000 375.000 1065.0000 3384.0000 759.0000

Trial Group Type

group_type Group_Count
Experimental 685
Placebo Comparator 208
Active Comparator 165
Other 57
NA 43
No Intervention 16
Sham Comparator 10

Intervention Model

intervention_model Study_Count
Parallel Assignment 362
Single Group Assignment 124
Crossover Assignment 15
Sequential Assignment 6
NA 5
Factorial Assignment 1

Primary Purpose

primary_purpose Study_Count
Treatment 392
Diagnostic 21
Other 21
Basic Science 20
Prevention 18
Supportive Care 17
NA 11
Health Services Research 9
Screening 4

Observational Studies

Studies by Country

Country Study_Count
United States 36
NA 15
France 11
Korea, Republic of 9
United Kingdom 9
Canada 7
United States|Canada 6
Denmark 5
China 4
Germany 4
Japan 4
Norway 4
Austria 3
Belgium 3
Hong Kong 3
Israel 3
Netherlands 3
Czech Republic 2
Italy 2
Saudi Arabia 2
Spain 2
Sweden 2
Argentina 1
Australia 1
Belarus|Kazakhstan|Russian Federation 1
Belgium|Czechia|Finland|France|Germany|Greece|Hungary|Italy|Netherlands|Portugal|Slovakia|Spain|United Kingdom 1
Brazil 1
Canada|Germany|Ireland|Italy|Netherlands|Poland|Sweden|United Kingdom 1
Croatia 1
Denmark|France|United States|Argentina|Australia|Austria|Belgium|Canada|Czechia|Germany|Israel|Netherlands|New Zealand|Switzerland|United Kingdom 1
Germany|United Kingdom 1
Greece 1
Hong Kong|Singapore|Taiwan 1
Portugal 1
Romania 1
Russian Federation 1
Saudi Arabia|Kuwait|Qatar|Algeria|Egypt 1
Taiwan|Argentina|China|Colombia|Korea, Republic of|Mexico|Russian Federation|Saudi Arabia|Singapore|Turkey 1
United States|Australia|Austria|Belgium|Canada|Croatia|Denmark|France|Germany|Greece|Ireland|Israel|Italy|Mexico|Netherlands|New Zealand|Norway|Puerto Rico|Spain|Sweden|United Kingdom 1
United States|Austria|Belgium|Canada|Croatia|Denmark|Estonia|France|Germany|Greece|Ireland|Israel|Italy|Netherlands|Norway|Portugal|Slovenia|Spain|Sweden|Switzerland|United Kingdom 1
United States|Austria|Canada|Czechia|France|Germany|Greece|Italy|Korea, Republic of|Spain 1

Sites per Study

Site_count Study_Count
1 111
2 8
3 1
4 3
6 1
7 2
8 2
9 1
10 1
12 1
13 1
15 4
19 1
21 1
23 1
24 1
26 1
30 2
36 1
41 1
61 1
63 1
76 1
80 2
103 1
105 1
108 1
140 1
149 1
159 1
287 1
515 1

Enrollment Metrics

Measure Observational
Min 1.000
1st Qu 67.000
Median 150.000
Mean 1387.829
3rd Qu 400.000
Max 92145.000

Observation Model

observational_model Study_Count
Cohort 101
Case-Only 21
Case-Control 16
Case Control 6
NA 6
Other 5
Case-Crossover 2
Ecologic or Community 1

Time Perspective

time_perspective Study_Count
Prospective 119
Retrospective 18
Cross-Sectional 17
Other 3
NA 1

Registries

Studies by Country

Country Study_Count
United States 5
Canada 3
Denmark 2
Netherlands 2
Belgium|Netherlands 1
Czechia 1
Germany 1
Hong Kong 1
Netherlands|United Kingdom 1
Norway 1
Spain 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 12
2 1
3 2
13 1
19 1
22 1
28 1
37 1

Enrollment Metrics

Measure Registries
Min 100.00
1st Qu 346.25
Median 650.00
Mean 2537.20
3rd Qu 2179.00
Max 15000.00

Registry Model

observational_model Study_Count
Cohort 17
Other 2
Case-Only 1

Time Perspective

time_perspective Study_Count
Prospective 17
Other 2
Cross-Sectional 1

Follow-up

target_duration Study_Count
5 Years 6
1 Year 4
20 Years 3
1 Day 1
16 Weeks 1
2 Years 1
25 Years 1
3 Years 1
54 Months 1
6 Months 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT02770599 Improving the Health Care in Inflammatory Bowel Disease. https://ClinicalTrials.gov/show/NCT02770599 Active, not recruiting University Hospital of North Norway 2020-03-20
NCT00001184 Immune Regulation in Ulcerative Colitis or Crohn s Disease https://ClinicalTrials.gov/show/NCT00001184 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT03397108 Assessing the Drug Exposure Risk of Infants Breastfed by Women With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03397108 Recruiting The Hospital for Sick Children 2020-07-31
NCT03801928 Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03801928 Completed Pfizer 2020-02-07
NCT03366090 Immunological Profiles in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03366090 Recruiting Rijnstate Hospital 2020-07-01
NCT03824561 Specified Drug-Use Survey on Vedolizumab for IV Infusion 300 mg [Ulcerative Colitis] https://ClinicalTrials.gov/show/NCT03824561 Recruiting Takeda 2022-01-31
NCT03282903 The PRognostic Effect of Environmental Factors in Crohn’s and Colitis https://ClinicalTrials.gov/show/NCT03282903 Recruiting University of Edinburgh 2020-10-31
NCT03223012 Impact of AbbVie Care Patient Support Program on Clinical, Health Economic and Patient Reported Outcomes, in Crohn’s Disease, Ulcerative Colitis, Rheumatoid Arthritis, Psoriatic Arthritis, Psoriasis and Axial Spondyloarthritis, in the Portuguese National Health Service https://ClinicalTrials.gov/show/NCT03223012 Completed AbbVie 2019-02-28
NCT03179865 Evaluation of Early Mucosal Healing During Clinical Remission in Pediatric Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03179865 Completed Wolfson Medical Center 2020-02-29
NCT03143517 Fecal Calprotectin Collection Protocol https://ClinicalTrials.gov/show/NCT03143517 Completed DiaSorin Inc. 2018-08-23
NCT03142113 Clinical Outcome After Escalation and De-escalation of Adalimumab in Real Life in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03142113 Completed Universitaire Ziekenhuizen Leuven 2016-12-31
NCT03090139 Sub-optimal Response to Anti-Tumor Necrosis Factor’s in Inflammatory Bowel Disease in Emerging Markets https://ClinicalTrials.gov/show/NCT03090139 Completed Takeda 2018-06-13
NCT03079700 Immune Modulation From Trichuris Suis https://ClinicalTrials.gov/show/NCT03079700 Completed University of Aarhus 2012-12-31
NCT03006198 Tracking Biologics Along the Silk Road https://ClinicalTrials.gov/show/NCT03006198 Completed Janssen Pharmaceutica N.V., Belgium 2018-12-01
NCT02986724 A Study to Observe the Safety and Efficacy of Vedolizumab in Biologically Naive Participants With Ulcerative Colitis (UC) or Crohn´s Disease (CD) https://ClinicalTrials.gov/show/NCT02986724 Active, not recruiting Takeda 2020-08-31
NCT02925338 National Observational Study On The Use Of Inflectraâ„¢ An Infliximab Biosimilar In Real Life https://ClinicalTrials.gov/show/NCT02925338 Recruiting Pfizer 2020-09-23
NCT02925260 MRI in Normal Ileal Pouches, and a Feasibility Study of Dynamic MRI Enema and Defaecating MRI Pouchography https://ClinicalTrials.gov/show/NCT02925260 Completed London North West Healthcare NHS Trust 2019-04-01
NCT02868398 Efficacy of Golimumab in Maintaining Deep Remission in UC Patients in Prolonged Remission With Infliximab https://ClinicalTrials.gov/show/NCT02868398 Completed Evangelismos Hospital 2020-04-30
NCT02846961 Anti CT-P13 Antibody in Moderate to Severe Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02846961 Recruiting Kyungpook National University Hospital 2018-09-30
NCT02808780 An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02808780 Recruiting Janssen Biotech, Inc. 2031-07-30
NCT02799615 Anti-TNF Therapy for Refractory Colitis in Hospitalized Children https://ClinicalTrials.gov/show/NCT02799615 Completed Children’s Hospital Medical Center, Cincinnati 2019-02-11
NCT02778464 Faecal Calprotectin as a Potential Non-invasive Inflammatory Marker in Pregnancy and Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02778464 Completed The Royal Wolverhampton Hospitals NHS Trust 2020-01-31
NCT02750800 Post-marketing Observational Study to Evaluate the Incremental Impact of AbbVie’s Patient Support Program on Patient Reported Outcomes and Health Resource Utilization in Inflammatory Arthritis, Psoriasis and Inflammatory Bowel Diseases in Hungary (VALUE) https://ClinicalTrials.gov/show/NCT02750800 Completed AbbVie 2018-04-03
NCT02745457 Body Composition in Children With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02745457 Active, not recruiting Schneider Children’s Medical Center, Israel 2020-05-30
NCT02735941 Study on Cannabinoid Receptor Expression in Gastrointestinal Diseases https://ClinicalTrials.gov/show/NCT02735941 Completed Medical University of Graz 2018-07-27
NCT02727959 Inflammatory Bowel Disease in South Eastern Norway https://ClinicalTrials.gov/show/NCT02727959 Completed Oslo University Hospital 2019-12-31
NCT02717897 Vitamin D and Disease Activity in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02717897 Completed University of Chicago 2013-05-31
NCT02693730 Phenotyping IBS: Perceptions and Modulations of Visceral Sensations https://ClinicalTrials.gov/show/NCT02693730 Active, not recruiting University of California, Los Angeles 2020-08-31
NCT02674308 Entyvio (Vedolizumab) Long Term Safety Study https://ClinicalTrials.gov/show/NCT02674308 Active, not recruiting Takeda 2021-07-22
NCT02640391 Predictive Factors of Endoscopic Mucosal Healing in Quiescent Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02640391 Completed Kyungpook National University Hospital 2018-12-31
NCT02586259 Effectiveness of Cortiment® in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02586259 Completed Ferring Pharmaceuticals 2018-04-05
NCT02678052 OTIS Vedolizumab Pregnancy Exposure Registry https://ClinicalTrials.gov/show/NCT02678052 Recruiting Takeda 2022-11-30
NCT03404557 Proteomic Analysis of Crohn’s Disease Macrophages in Response or Not to AIEC https://ClinicalTrials.gov/show/NCT03404557 Completed University Hospital, Clermont-Ferrand 2019-01-18
NCT02738125 Assessing Effectiveness of Adalimumab for Treating Ulcerative Colitis in Real Life Conditions https://ClinicalTrials.gov/show/NCT02738125 Active, not recruiting AbbVie 2028-11-20
NCT02542917 Home Versus Postal Testing for Faecal Calprotectin: a Feasibility Study https://ClinicalTrials.gov/show/NCT02542917 Completed King’s College Hospital NHS Trust 2016-07-31
NCT02539368 Post-Marketing Use Of CT-P13 (Infliximab) For Standard Of Care Treatment Of Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02539368 Completed Pfizer 2018-10-31
NCT02506179 Impact of Adalimumab on Patient-reported Outcomes in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02506179 Completed AbbVie 2020-02-10
NCT02502552 Study of Anti-glycan Antibodies Stability in Saint-Etienne IBD Cohort https://ClinicalTrials.gov/show/NCT02502552 Completed Centre Hospitalier Universitaire de Saint Etienne 2015-10-31
NCT02499263 A Prospective Non-interventional Multicenter Study to Evaluate the Effectiveness of Adalimumab in Korean Patients With Ulcerative Colitis (UC) and Identify Potential Predictors of Clinical Response in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT02499263 Completed AbbVie 2018-09-17
NCT02439372 Assessment of CMV-specific ELISPOT Assay for Predicting CMV Colitis in Patient With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02439372 Completed Asan Medical Center 2016-06-30
NCT02438410 Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02438410 Completed Mayo Clinic 2019-12-04
NCT02399683 Immune Modulation From Trichuris Trichiura https://ClinicalTrials.gov/show/NCT02399683 Completed University of Aarhus 2012-12-31
NCT02368743 QUality of Life in pAtients With Mild to modeRate Active procTitis Treated by mesalaZine (Pentasa®) https://ClinicalTrials.gov/show/NCT02368743 Completed Ferring Pharmaceuticals 2017-03-31
NCT02322008 Anti-TNF Therapy in Danish Patients With Inflammatory Bowel Diseases in Clinical Practice https://ClinicalTrials.gov/show/NCT02322008 Completed Regionshospitalet Viborg, Skive 2011-03-31
NCT02316678 Patient Attitudes and Preferences for Outcomes of Inflammatory Bowel Disease Therapeutics https://ClinicalTrials.gov/show/NCT02316678 Completed University of Pennsylvania 2016-12-31
NCT02274714 Dysmenorrhea in Women With Crohn’s Disease and Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02274714 Completed University of Wisconsin, Madison 2017-01-31
NCT02229344 Study of Clinical Course of Newly Diagnosed Moderate to Severe Ulcerative Colitis in Korea https://ClinicalTrials.gov/show/NCT02229344 Active, not recruiting Janssen Korea, Ltd., Korea 2022-02-22
NCT02161640 Vascular Dysfunction in Paediatric IBD https://ClinicalTrials.gov/show/NCT02161640 Completed Great Ormond Street Hospital for Children NHS Foundation Trust 2016-11-30
NCT02149043 Thermography in Surveillance of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02149043 Completed University Hospital Dubrava 2018-01-31
NCT02135289 The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID https://ClinicalTrials.gov/show/NCT02135289 Completed Chinese University of Hong Kong 2019-07-31
NCT02110862 Scintigraphic Evaluation of IPAA Function in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT02110862 Completed Odense University Hospital 2013-08-31
NCT01301976 Nutritional State and Intake Nutrients Assessment in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01301976 Completed UPECLIN HC FM Botucatu Unesp 2010-03-31
NCT01289366 Endocytoscopy for in Vivo Determination of Mucosal Inflammatory Cells and Intestinal Disease Activity in Inflammatory Bowel Disease (IBD) https://ClinicalTrials.gov/show/NCT01289366 Completed University of Erlangen-Nürnberg Medical School 2011-08-31
NCT01282905 Hydrogen Sulfide Detoxification and Butyrate Metabolism in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01282905 Completed KU Leuven NA
NCT02057016 Long-term Scheduled Therapy With Infliximab in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02057016 Completed Catholic University of the Sacred Heart 2014-12-31
NCT02054533 Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02054533 Completed Icahn School of Medicine at Mount Sinai 2017-06-30
NCT01966744 Self-Management Assistance for Recommended Treatment (SMART) Portal https://ClinicalTrials.gov/show/NCT01966744 Completed Children’s Hospital Medical Center, Cincinnati 2016-06-30
NCT01960439 Responsiveness of Endoscopic Evaluation in UC https://ClinicalTrials.gov/show/NCT01960439 Completed University of Western Ontario, Canada 2015-07-31
NCT01947816 Special Investigation in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01947816 Completed AbbVie 2018-02-15
NCT01931644 At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions https://ClinicalTrials.gov/show/NCT01931644 Recruiting Sanguine Biosciences 2025-08-31
NCT01916161 The Influence of Information Sources on Knowledge and Anxiety in Inflammatory Bowel Disease Patients https://ClinicalTrials.gov/show/NCT01916161 Completed National Health Service, United Kingdom 2016-02-29
NCT01891214 Validation of the French Version of the Inflammatory Bowel Disease Questionnaire (IBDQ) for Ulcerative Colitis and Crohn’s Disease https://ClinicalTrials.gov/show/NCT01891214 Completed Rennes University Hospital 2016-04-30
NCT01861288 Deep Endoscopic Remission Assessed by a Surrogate Biomarker in Patients With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT01861288 Completed Herlev Hospital 2016-09-05
NCT01852760 Assessment of Disease Activity in Ulcerative Colitis by Endoscopic Ultrasound https://ClinicalTrials.gov/show/NCT01852760 Completed Lawson Health Research Institute 2015-07-31
NCT01848561 A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT01848561 Recruiting AbbVie 2027-04-06
NCT01813500 Host Immune Response to Clostridium Difficile Infection in Inflammatory Bowel Disease Patients https://ClinicalTrials.gov/show/NCT01813500 Completed Boston Medical Center 2015-09-30
NCT01798953 Surgical Reconstruction in Ulcerative Colitis With Primary Sclerosing Cholangitis https://ClinicalTrials.gov/show/NCT01798953 Completed Sahlgrenska University Hospital, Sweden 2013-02-28
NCT01768858 Assessment of Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, Plaque Psoriasis, Crohn’s Disease and Ulcerative Colitis Patients´ Adherence Attitudes to Maintenance Therapy With a Scheduled Adalimumab Treatment in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT01768858 Completed AbbVie 2017-08-13
NCT01740349 Evaluation Of The Pillcamâ„¢ Colon Capsule Endoscopy (Pcce-2) In Pediatric Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01740349 Completed Azienda Policlinico Umberto I 2012-09-30
NCT01705522 Multimodal Approach in IBD Patients https://ClinicalTrials.gov/show/NCT01705522 Recruiting Clinical Hospital Colentina 2019-09-30
NCT01678300 Qualitative Study of Topical Mesalamine Adherence in Patients With Ulcerative Colitis(UC) https://ClinicalTrials.gov/show/NCT01678300 Completed Beth Israel Deaconess Medical Center 2015-11-30
NCT01676324 FOCUS: The Future of Fecal Calprotectin Utility Study for the Diagnosis and Management of Inflammatory Bowel Disease (IBD) https://ClinicalTrials.gov/show/NCT01676324 Completed University of British Columbia 2013-03-31
NCT01654783 Observational Study in the Management of Ulcerative Colitis With Oral 5-ASA https://ClinicalTrials.gov/show/NCT01654783 Completed Kyorin Pharmaceutical Co.,Ltd 2014-06-30
NCT01604564 Registry With Information About Colitis Ulcerosa and Familial Adenomatous Polyposis Patients https://ClinicalTrials.gov/show/NCT01604564 Active, not recruiting Universitaire Ziekenhuizen Leuven 2019-12-31
NCT01517607 Mesalazine (PENTASA®) in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01517607 Completed Ferring Pharmaceuticals 2013-12-31
NCT01517594 Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01517594 Completed Ferring Pharmaceuticals 2013-06-30
NCT01517516 Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest. https://ClinicalTrials.gov/show/NCT01517516 Completed University of California, Los Angeles 2015-07-31
NCT01468090 Disease Course in an IBD Cohort in the Era of Biological Treatment https://ClinicalTrials.gov/show/NCT01468090 Completed Hvidovre University Hospital 2014-06-30
NCT01467609 PillCam Colon Capsule Endoscopy for Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01467609 Completed Shanghai Jiao Tong University School of Medicine 2010-07-31
NCT01405105 Exacerbating Factors in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT01405105 Completed Dallas VA Medical Center 2012-06-30
NCT01387698 Prospective, Longitudinal Multicentric Survey in the Therapeutic Care of Mild to Moderate Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01387698 Completed Ferring Pharmaceuticals 2015-10-31
NCT01364896 Anal Human Papillomavirus in Inflammatory Bowel Disease Study https://ClinicalTrials.gov/show/NCT01364896 Completed University of Pittsburgh 2014-01-31
NCT01363453 User Surveillance in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01363453 Completed Ferring Pharmaceuticals 2008-05-31
NCT01349504 Adherence to Mesalamine Profile for Patients With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT01349504 Completed Beth Israel Deaconess Medical Center 2012-12-31
NCT01331551 Mesalamine and Reproductive Health Study https://ClinicalTrials.gov/show/NCT01331551 Completed Harvard School of Public Health 2018-08-31
NCT04272307 MIcroorganisms as Triggers in Acute Severe Ulcerative Colitis and Their Influence on Medical Therapy Efficacy: a Multi-omics Pilot Approach. https://ClinicalTrials.gov/show/NCT04272307 Recruiting University Hospital, Bordeaux 2021-02-28
NCT04197973 Association Between Self-reported Web-based SCCAI and Health-related Quality of Life Index in UC Patients https://ClinicalTrials.gov/show/NCT04197973 Recruiting Keimyung University Dongsan Medical Center 2020-06-20
NCT04191707 Metabolomic Markers of Fatigue in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT04191707 Completed Corporacion Parc Tauli 2019-12-01
NCT04191395 Evolution and Treatments of Chronic Inflammatory Systemic Diseases https://ClinicalTrials.gov/show/NCT04191395 Recruiting Centre Hospitalier Universitaire de Besancon 2029-12-31
NCT04151420 Real Life Remote Monitoring of Mild, Moderate and Severe Infectious Complications in IBD by Patient Reported Assessment https://ClinicalTrials.gov/show/NCT04151420 Recruiting Maastricht University Medical Center 2021-11-30
NCT04148274 A Non-Interventional Pilot Study to Explore the Role of Gut Flora in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04148274 Recruiting ProgenaBiome 2023-03-31
NCT04131530 Automatic Evaluation of Inflammation Activity in Ulcerative Colitis Using pCLE With Artificial Intelligence https://ClinicalTrials.gov/show/NCT04131530 Recruiting Shandong University 2019-12-31
NCT04089514 A Real-world Study of Imraldi® Use https://ClinicalTrials.gov/show/NCT04089514 Recruiting Biogen 2021-06-30
NCT04079335 A Prospective Longitudinal Study of Fecal Microbiome and Calprotectin to Predict Relapse in Patients With IBD https://ClinicalTrials.gov/show/NCT04079335 Recruiting Chinese University of Hong Kong 2021-01-28
NCT03262649 Manitoba Inflammatory Bowel Disease Cohort Study https://ClinicalTrials.gov/show/NCT03262649 Completed University of Manitoba 2016-03-01
NCT03952364 The PRECIOUS Study: Predicting Crohn’s & ColitIs Outcomes in the United States https://ClinicalTrials.gov/show/NCT03952364 Recruiting PredictImmune Ltd 2021-06-30
NCT03952195 Complications and Outcomes of Pouch Excision https://ClinicalTrials.gov/show/NCT03952195 Completed Icahn School of Medicine at Mount Sinai 2017-04-01
NCT03947931 Russian Extremely Severe Ulcerative Colitis Study https://ClinicalTrials.gov/show/NCT03947931 Recruiting State Scientific Centre of Coloproctology, Russian Federation 2021-06-20
NCT03942861 Sonographic Assessment in Severe Ulcerative Colitis Patients Admitted for Intravenous Corticosteroids and Eligible for Infliximab Rescue Therapy; a Prospective Clinician-blinded Observational Study Protocol. https://ClinicalTrials.gov/show/NCT03942861 Recruiting Copenhagen University Hospital at Herlev 2020-08-21
NCT03907631 Multi-centre Acute Severe Ulcerative Colitis Prospective Cohort Study (Elevate ASUC) https://ClinicalTrials.gov/show/NCT03907631 Recruiting Hull University Teaching Hospitals NHS Trust 2020-09-01
NCT03884439 Infliximab Biosimilar “Pfizer” Drug Use Investigation (Crohn’s Disease or Ulcerative Colitis) https://ClinicalTrials.gov/show/NCT03884439 Recruiting Pfizer 2023-03-13
NCT03841045 Unraveling a Potential Connection Between Bilirubin Metabolism, Gut Microbiota and Inflammatory Bowel Diseases https://ClinicalTrials.gov/show/NCT03841045 Recruiting Soroka University Medical Center 2020-12-31
NCT03839680 Measuring Endoscopic ACTIvity in Patients Treated With VEDOlizumab for Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03839680 Recruiting Centre Hospitalier Universitaire de Besancon 2019-04-15
NCT03836612 Healthcare Resource Utilisation, Common Mental Health Problems, and Infections in People With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03836612 Completed Momentum Data 2019-09-01
NCT03808506 Relationship Between Baseline Burden of Disease and TDM in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03808506 Recruiting Lawson Health Research Institute 2021-06-30
NCT03802214 Ulcerative Colitis - Vedolizumab- With/Without Prior Exposure to Anti-TNF(Tumor Necrosis Factor)Therapy https://ClinicalTrials.gov/show/NCT03802214 Recruiting Stanford University 2021-12-31
NCT03788824 Evaluation of Inflammation Activity in Ulcerative Colitis by pCLE https://ClinicalTrials.gov/show/NCT03788824 Recruiting Shandong University 2018-12-31
NCT03773445 Golimumab Trough Levels in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03773445 Recruiting Hospital San Carlos, Madrid 2019-10-31
NCT03765450 Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03765450 Recruiting Robarts Clinical Trials Inc. 2019-12-31
NCT03747068 The Influence of Biologcal Treatment on the Short-Term Complications of Surgery in Patients With Inflematory Bowel Disease. https://ClinicalTrials.gov/show/NCT03747068 Completed HaEmek Medical Center, Israel 2015-10-09
NCT03710486 A Study to Observe Vedolizumab and Anti-tumour Necrosis Factors (Anti-TNFs) Outcomes in Real-world Biologic Ulcerative Colitis (UC) and Crohn’s Disease (CD) Participants https://ClinicalTrials.gov/show/NCT03710486 Recruiting Takeda 2021-09-30
NCT03698812 A Multicenter Prospective Cohort Study on the Clinical Prognosis of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03698812 Recruiting Nanfang Hospital of Southern Medical University 2020-09-30
NCT03689673 Study of the Effectiveness of ETIASA® (Sustained Release 5-Aminosalicylate) in Maintenance Treatment of Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT03689673 Active, not recruiting Ipsen 2020-12-31
NCT03669822 Multi-center Acute Severe Ulcerative Colitis Cohort Study (MASCC) https://ClinicalTrials.gov/show/NCT03669822 Recruiting Johns Hopkins University 2020-12-31
NCT03662919 One-year Persistence to Treatment of Participants Receiving Flixabi or Imraldi: a French Cohort Study https://ClinicalTrials.gov/show/NCT03662919 Recruiting Biogen 2022-06-30
NCT03643211 Xeljanz Special Investigation for Long-term Use in UC Patients https://ClinicalTrials.gov/show/NCT03643211 Active, not recruiting Pfizer 2022-01-05
NCT03640637 The Role of PET/MRI in the Diagnosis and Treatment of Children and Adolescents With Inflammatory Bowel Diseases https://ClinicalTrials.gov/show/NCT03640637 Enrolling by invitation Odense University Hospital 2020-12-31
NCT03589183 Gut Microbiome in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03589183 Recruiting Kyunghee University Medical Center 2028-03-31
NCT03578692 Indicators Predicting Surgery in Acute Severe Ulcerative Colitis(ASUC) https://ClinicalTrials.gov/show/NCT03578692 Completed Nanjing PLA General Hospital 2018-01-31
NCT03565432 Sick Leave, Work Disability and Quality of Life in Korean Patients With Inflammatory Bowel Diseases https://ClinicalTrials.gov/show/NCT03565432 Active, not recruiting Kyunghee University Medical Center 2019-07-30
NCT03553472 Identifying Young Inflammatory Bowel Disease Patients at Risk for Herpes Zoster https://ClinicalTrials.gov/show/NCT03553472 Completed University of Wisconsin, Madison 2019-05-31
NCT03549988 Pro-active Fecal Calprotectin Monitoring PROMOTE-UC https://ClinicalTrials.gov/show/NCT03549988 Recruiting University of British Columbia 2020-06-30
NCT03532932 A Study to Evaluate Disease Control and Treatment Pattern in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) in Real Life Practice https://ClinicalTrials.gov/show/NCT03532932 Recruiting Takeda 2021-07-15
NCT03501758 Predicting Relapse of Ulcerative Colitis With Gastrointestinal Ultrasound https://ClinicalTrials.gov/show/NCT03501758 Recruiting Haukeland University Hospital 2023-12-30
NCT03488030 A Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life in Participants With Moderate to Severe Inflammatory Bowel Disease (IBD) https://ClinicalTrials.gov/show/NCT03488030 Completed Takeda 2019-05-31
NCT03477032 FMT in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03477032 Recruiting St Vincent’s Hospital Melbourne 2019-12-31
NCT03460847 Fecal Microbiota Alterations in Steroid Refractory Active Colitis Ulcerosa https://ClinicalTrials.gov/show/NCT03460847 Recruiting Medical University of Graz 2020-03-31
NCT03452501 Safety and Effectiveness Study of Remsima® in the Treatment of Inflammatory Bowel Diseases Among Saudi Arabia Patients https://ClinicalTrials.gov/show/NCT03452501 Active, not recruiting Hikma Pharmaceuticals LLC 2020-06-30
NCT01169207 Johns Hopkins Crohn’s Disease and Ulcerative Colitis Study https://ClinicalTrials.gov/show/NCT01169207 Active, not recruiting Johns Hopkins University 2020-12-31
NCT01140789 GWA Study in Patients With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT01140789 Recruiting Chinese University of Hong Kong 2037-04-30
NCT01104753 A Study of Pentasa in Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT01104753 Completed Ferring Pharmaceuticals 2010-10-31
NCT01099111 Advanced Metagenomic Analysis of Human Colonic Microbiota in Patients With Chronic GI Disorders https://ClinicalTrials.gov/show/NCT01099111 Completed King Fahad Medical City 2012-01-31
NCT01095432 Partial Wave Spectroscopic Detection of Colon Cancer Risk https://ClinicalTrials.gov/show/NCT01095432 Completed University of Chicago 2015-11-30
NCT01091558 Study of Effects of L-Arginine in Colitis and Colon Cancer https://ClinicalTrials.gov/show/NCT01091558 Completed Vanderbilt University Medical Center 2011-12-31
NCT01032525 Monroe County Inflammatory Bowel Disease (IBD) Registry https://ClinicalTrials.gov/show/NCT01032525 Completed University of Rochester 2013-05-31
NCT00961948 Indigo Carmine Staining and Narrow Band Imaging (NBI) of Colonic Mucosa for Detection of Dysplasia in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00961948 Completed Mayo Clinic 2013-02-28
NCT00917514 An Investigational Study to Test Usability of the Electronic Dosing Equipment Medicpen https://ClinicalTrials.gov/show/NCT00917514 Completed Medicpen AB 2010-02-28
NCT02423512 The Impact of Anti-TNF Exposure on Vedolizumab Effectiveness https://ClinicalTrials.gov/show/NCT02423512 Completed Icahn School of Medicine at Mount Sinai 2017-06-13
NCT02261636 Induction and Maintenance of Remission With Pentasa as Ulcerative Colitis Treatment https://ClinicalTrials.gov/show/NCT02261636 Completed Ferring Pharmaceuticals 2019-01-14
NCT01301417 Data Collection of Patients Treated With the ColonRingâ„¢ for the Creation of Circular Compression Anastomosis https://ClinicalTrials.gov/show/NCT01301417 Completed novoGI 2011-08-31
NCT04411784 PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis https://ClinicalTrials.gov/show/NCT04411784 Active, not recruiting Hull University Teaching Hospitals NHS Trust 2020-07-31
NCT03663400 Identify Predictors That Distinguish Between Tofacitinib Responders and Non-responders Based on Genotype and Cellular and Molecular Profiles From Pinch Biopsies, Blood and Stool Samples https://ClinicalTrials.gov/show/NCT03663400 Recruiting NYU Langone Health 2020-09-30
NCT03535649 A Study to Assess Clinical Effectiveness and Safety of Vedolizumab Intravenous in Real World Clinical Practice in Ulcerative Colitis (UC) Korean Participants https://ClinicalTrials.gov/show/NCT03535649 Completed Takeda 2018-12-18
NCT00780507 Fecal Biomarker Study for Patients With Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00780507 Completed Warner Chilcott 2009-07-31
NCT00705484 European Safety Registry in Ulcerative Colitis (P04808) https://ClinicalTrials.gov/show/NCT00705484 Completed Merck Sharp & Dohme Corp. 2016-10-20
NCT00606346 A Multicenter, Prospective, Long-term, Observational Registry of Pediatric Patients With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00606346 Active, not recruiting Janssen Biotech, Inc. 2037-11-15
NCT00604422 Evaluation of the PillCamâ„¢ Colon Capsule Endoscopy (PCCE) in Detection & Classification of Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00604422 Completed Medtronic - MITG 2010-02-28
NCT00587236 Compare Conventional Colonosocpy to Endoscopic AFI, NBI for Dysplasia Detection for Ulcerative Colitis & Cholangitis https://ClinicalTrials.gov/show/NCT00587236 Completed Mayo Clinic 2010-08-31
NCT00516776 The Innate Immune System and Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00516776 Completed Norwegian University of Science and Technology 2017-12-31
NCT00474097 Follow-Up Phone Calls After Colorectal Surgery https://ClinicalTrials.gov/show/NCT00474097 Completed University Hospitals Cleveland Medical Center 2007-12-31
NCT00468455 Post-Op Quality of Life After Colorectal Surgery https://ClinicalTrials.gov/show/NCT00468455 Completed University Hospitals Cleveland Medical Center 2008-04-30
NCT00463619 Follow-up Study With Retarded Release Phosphatidylcholine in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00463619 Completed Heidelberg University 2010-04-30
NCT00403923 Amount of Lactose Causing Symptoms in People With Lactose Intolerance and Ulcerative Colitis https://ClinicalTrials.gov/show/NCT00403923 Completed University Hospitals, Leicester 2007-06-30
NCT00274209 Chromoendoscopy for Ulcerative Colitis Surveillance https://ClinicalTrials.gov/show/NCT00274209 Completed Indiana University 2011-11-30
NCT00222378 Prevalence of Cytomegalovirus, Epstein Barr Virus and Human Herpes 6 Virus in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00222378 Completed University of Miami 2012-06-30
NCT00215020 Evaluation of Urinary Isoprostanes in the Assessment of Children With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00215020 Completed Boston Children’s Hospital 2006-06-30
NCT00207688 A Long Term Safety Study of Infliximab (Remicade) in in Ulcerative Colitis Patients https://ClinicalTrials.gov/show/NCT00207688 Completed Janssen Research & Development, LLC 2015-09-09
NCT00061737 Quality of Life in Pediatric Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT00061737 Completed National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) NA

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT03173144 Chronic Inflammatory Disease, Lifestyle and Treatment Response https://ClinicalTrials.gov/show/NCT03173144 Recruiting University of Southern Denmark 2019-03-31
NCT03824418 The Clinical Value of Chromoendoscopy as Surveillance Strategy for Dysplasia Detection in Ulcerative Colitis https://ClinicalTrials.gov/show/NCT03824418 Completed Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 2018-05-09
NCT03257345 VEST: The UK Vedolizumab Real Life Experience Study in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03257345 Recruiting University Hospital Southampton NHS Foundation Trust 2019-09-30
NCT03251118 A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03251118 Recruiting Target PharmaSolutions, Inc. 2025-07-31
NCT03131414 The IMAGINE-SPOR CIHR Chronic Disease Network https://ClinicalTrials.gov/show/NCT03131414 Recruiting Hamilton Health Sciences Corporation 2022-06-01
NCT02791854 Improving the Quality of Care for Adults With Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02791854 Enrolling by invitation Dartmouth-Hitchcock Medical Center 2030-12-31
NCT02612103 Biomarkers in Inflammatory Bowel Diseases https://ClinicalTrials.gov/show/NCT02612103 Completed Odense University Hospital 2018-01-31
NCT02503514 Autoimmune Paradoxical Reactions in IBD Longitudinal Cohort https://ClinicalTrials.gov/show/NCT02503514 Completed University of North Carolina, Chapel Hill 2017-08-31
NCT02326155 To Evaluate the Safety and Efficacy of Remsimaâ„¢ in Patients With Crohn’s Disease (CD) or Ulcerative Colitis (UC) https://ClinicalTrials.gov/show/NCT02326155 Recruiting Celltrion 2020-06-30
NCT02308917 Canadian Children Inflammatory Bowel Disease Network (CIDsCANN) https://ClinicalTrials.gov/show/NCT02308917 Recruiting The Hospital for Sick Children 2023-12-31
NCT02197780 Head-to-head Comparison of Two Fecal Biomarkers to Screen Children for IBD https://ClinicalTrials.gov/show/NCT02197780 Completed University Medical Center Groningen 2017-03-31
NCT02131168 Epidemiology of IBD in Hong Kong: An Inception Cohort and Follow up Study https://ClinicalTrials.gov/show/NCT02131168 Recruiting Chinese University of Hong Kong 2021-03-31
NCT02130349 IBDSL Biobank Project. Molecular Markers for Diagnosis and Therapy Response in IBD. https://ClinicalTrials.gov/show/NCT02130349 Recruiting Maastricht University Medical Center 2020-12-31
NCT02073526 Anti-TNF-alpha Trough Level Measurements in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT02073526 Completed Oslo University Hospital 2016-05-31
NCT04243525 Inflammatory Bowel Disease (IBD) Research Registry https://ClinicalTrials.gov/show/NCT04243525 Recruiting University of Pittsburgh 2030-05-31
NCT04032756 Tofacitinib Registry of Patients With Ulcerative Colitis in Germany https://ClinicalTrials.gov/show/NCT04032756 Recruiting Ced Service GmbH 2023-03-31
NCT03872726 Development and Validation of a Self-reported Objective Index of Work Disability in Inflammatory Bowel Disease https://ClinicalTrials.gov/show/NCT03872726 Recruiting Corporacion Parc Tauli 2019-05-30
NCT03772145 Tofacitinib Response in Ulcerative Colitis - a Real World Prospective Multi-center Study https://ClinicalTrials.gov/show/NCT03772145 Enrolling by invitation University of North Carolina, Chapel Hill 2020-12-31
NCT03729674 Comparative Effectiveness and Safety of Biosimilar and Legacy Drugs https://ClinicalTrials.gov/show/NCT03729674 Recruiting McGill University Health Centre/Research Institute of the McGill University Health Centre 2021-03-30
NCT03571373 PIBD-SETQuality; the PIBD-NET Inception Cohort and Safety Registry https://ClinicalTrials.gov/show/NCT03571373 Recruiting PIBD-Net 2020-12-31